<ѻý>FDA Approves New Valbenazine Formulation (Neurocrine Biosciences)ѻý> One 80-mg capsule once daily for tardive dyskinesia Oct 05, 2017
<ѻý>FDA Panel Backs New Warning for Gadolinium Contrast Agentsѻý> Manufacturers could be required to conduct new studies Sep 11, 2017
<ѻý>Does a New Hepatitis Vaccine Cause Heart Attacks?ѻý> In this Revolution and Revelation, Milton Packer asks how you would answer this question Aug 02, 2017
<ѻý>Gilead's 3-Drug Combo Pill OK'd for 2nd-Line HCV Treatmentѻý> Indicated for all six HCV genotypes in patients needing retreatment Jul 18, 2017
<ѻý>FDA Eyeing Patient-Reported Outcomes in Huntington's, Parkinson'sѻý> Some non-motor symptoms may be ideal 'PRO' candidates Jun 06, 2017
<ѻý>REMS Impact on Opioid Overdose Rates Unclearѻý> Overdoses fell but deaths did not in claims analysis Mar 20, 2017
<ѻý>FDA Issues Warning on IBS Drug Viberziѻý> Must be avoided in patients whose gallbladders have been removed Mar 15, 2017
<ѻý>Scott Gottlieb's Sham Ideology Rejects Clinical Trialsѻý> The next FDA commissioner doesn't believe in trials with sham controls Mar 14, 2017
<ѻý>FDA Again Warns on Balloon Angioplasty for Neurologic Disordersѻý> Says transvascular autonomic modulation is off-label and dangerous Mar 08, 2017
<ѻý>FDA Okays Marathon's Emflaza for DMDѻý> Corticosteroids already commonly used to treat the condition Feb 09, 2017
<ѻý>Eteplirsen Approval Seen as Marking New Direction at FDAѻý> Decision on rare-disease drug sparked major controversy Dec 28, 2016
<ѻý>Knee Cartilage Repair Product Wins FDA Nodѻý> First of its kind to be approved, agency says Dec 13, 2016
<ѻý>Lowering the Bar: How PMDD Went from an Idea to a Diagnosisѻý> Sometimes the drug comes first Nov 16, 2016
<ѻý>TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane?ѻý> FDA Commissioner and E.U. representative talk change Nov 02, 2016
<ѻý>FDA Warns of Testosterone Abuseѻý> Adverse events tied to abuse include heart attack, heart failure, and stroke Oct 25, 2016
<ѻý>FDA Warns on Cardiac Surgery Heater-Cooler Deviceѻý> Cites mycobacterial contamination risk Oct 13, 2016
<ѻý>AAFP Blinks on Single-Payer and DTC Drug Adsѻý> AAFP delegates stopped short of making new policy on single-payer and a ban on DTC ads Sep 20, 2016
<ѻý>FPs Decry Soaring Drug Pricesѻý> AAFP delegates want relief for cash-strapped patients Sep 19, 2016
<ѻý>Lowering the Bar: Love Potion Number 9 Million?ѻý> Is the history of "low T" and "hypoactive sexual desire disorder" a tale of profit trumping science? Jul 06, 2016
<ѻý>FDA Panel Splits on Expanded Jardiance Indicationѻý> Questions raised about key trial Jun 28, 2016
<ѻý>New Trial 'Justifies' FDA Nod for Ibranceѻý> Phase III study had almost identical results as pivotal trial Jun 08, 2016
<ѻý>FDA Warns of Heart Risk with Imodiumѻý> Permanent and fatal arrhythmias tied to misuse of loperamide Jun 07, 2016
<ѻý>Unapproved Wound Care Products Flood the Marketѻý> Expert: Closer regulation could prevent many amputations Jun 01, 2016
<ѻý>ADHD: How Did It Leap from Classroom to Boardroom?ѻý> Adults are now routinely diagnosed with ADHD. Why is that? This Lowering the Bar; Medicine in 21st Century report seeks answers May 22, 2016
<ѻý>Gluttony -- Once a Deadly Sin, Now a Treatable Disorderѻý> This "Lowering the Bar: Medicine in the 21st Century" ѻýToday/Milwaukee Journal Sentinel report takes a hard look at binge-eating disorder May 22, 2016
<ѻý>Smartphone App May Help Monitor Depressionѻý> Patients were amenable to data monitoring by docs May 15, 2016
<ѻý>How to Avoid Misdiagnosisѻý> How a patient makes you feel may affect your diagnostic acumen May 13, 2016
<ѻý>FDA: Avoid Cipro, Similar Drugs for Common Infectionsѻý> Agency says risks outweigh benefits May 12, 2016
<ѻý>FDA Warns of Skin Reaction With Olanzapineѻý> Zyprexa and Symbyax among products to get warning label May 10, 2016
<ѻý>FDA Warning: Abilify Tied to Impulse Control Problemsѻý> In rare cases, may prompt "uncontrollable urges" May 03, 2016
<ѻý>Saxagliptin, Alogliptin Linked to Heart Failure, FDA Warnsѻý> Decision comes 1 year after FDA advisory committee vote Apr 05, 2016
<ѻý>FDA Lifts Restriction On Rosiglitazoneѻý> Agency sees no need for restrictions after easing them 2 years ago Dec 16, 2015
<ѻý>Slippery Slope: A Targeted Therapy That Misses the Mark?ѻý> Afinitor racks up FDA approvals, but where is the evidence? Dec 13, 2015
<ѻý>FDA Advisory Panel Unmoved by Gepirone Dataѻý> Recommends against novel antidepressant; FDA's fairness questioned Dec 02, 2015
<ѻý>Evidence Lacking for Some Fluoroquinolone Useѻý> FDA panel says risk-benefit data don't support current labeling Nov 06, 2015
<ѻý>FDA Presses Pause on Novel Testosterone Productѻý> Gives FDA chance to "back away from the circus," says sponsor's CEO Nov 02, 2015